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CL is a 54 year old perimenopausal, nulliparous, morbidly obese
Caucasian woman who was referred to gynecologic oncology after
discovery of peritoneal implants on CT scan of the abdomen and pelvis,
obtained for persistent epigastric pain. She denied history of weight
loss, bloating, constipation, pelvic pain, or dysuria. Her history included
laparoscopic splenectomy thirteen years prior for idiopathic thrombo-
cytopenic purpura (ITP), and she had no family history of cancer.
Abdominal and rectopelvic examinations were normal. Cancer
antigen 125 and carcinoembryonic antigen levels were within normal
limits. CT review identiﬁedmultiple small enhancing anterior peritone-
al nodular implants without evidence of pelvic mass (Fig. 1A). Given
pronounced imaging ﬁndings, resolution of prior symptoms, and his-
tory of splenectomy, a positron emission tomography (PET) scan was⁎ Corresponding author at: The Ohio State University/Mount Carmel Health OB/GYN
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(Fig. 1B).
As the case was highly suspicious for a malignant process, the pa-
tient was consented for exploratory laparotomy and debulking. Intra-
operatively, the greater omentum hadmultiple small maroon nodules
under 3 cm in size (Fig. 2). Extensive implantation was observed
along the anterolateral abdominal walls, small and large bowel, blad-
der, uterus, ovaries, and tubes. A partial omentectomy was performed
and sent for frozen and permanent section. Pathologist review of fro-
zen sections found lymphoid tissue favoring spleen which conﬁrmed
our clinical suspicions. Complete survey found otherwise normal
abdominopelvic organs, and the abdomen was closed. The ﬁnal pa-
thology report described unremarkable spleen, conﬁrmed by ﬂow cy-
tometry revealing normal lymphoid populations. When the patient
returned to the ofﬁce for post-operative examination, she had a pe-
ripheral blood smear that showed no Howell–Jolly bodies.
We reviewed her splenectomy operative report which described
laparosocpic excision with morcellation and removal through an en-
doscopic bag without spillage. No comment was made of splenic nod-
ules. The patient's platelet count four months prior to splenectomy
was 21 K/μL, rising to 383 K/μL the day of splenectomy with medical
therapy, then rising to 583 K/μL one month following surgery. Her
platelet count was 432 K/μL at the time of consultation thirteen
years later.Discussion
Splenosis is deﬁned as ectopic splenic tissue commonly arising
from splenic trauma-induced autotransplantation, or rarely as con-
genital accessory spleens or polysplenia (Fremont and Todd, 2007;
Lake et al., 2012). Ninety three percent of splenosis cases follow ab-
dominal trauma, and arises after 65% of splenic ruptures (Fremont
and Todd, 2007; Ksiadzyna and Peña, 2011; Malik et al., 2012).
Small (b3 cm) visceroperitoneal implants are typically found, and
secondary splenosis is associated with greater implant quantity
(maximum of 400 reported) compared to congenital origins (up to
10) (Fremont and Todd, 2007; Ksiadzyna and Peña, 2011). Implants
may arise months to years following initial insult, and may be func-
tional such as in recurrence of ITP (Ksiadzyna and Peña, 2011).
These implants may mimic carcinomatosis upon front line imaging
modalities (Neri et al., 1986; White et al., 1989; Short et al., 2011;
Stovall and Ling, 1988; Mikhael et al., 2009).
Fig. 1. A: CT scan with IV contrast, coronal section at L5 showing anterior peritoneal
wall implants on the patient’s right. B: PET scan showing metabolic hyperactivity in
these same implants.
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Meta-analysis of 23 reports of ITP relapse following laparoscopic
splenenectomy (74% performed for ITP) was 43.6 per 1000 patient
years, 1–5 years post-operatively (Mikhael et al., 2009). Khatkouda et
al. compare their post-splenectomy ITP recurrence risk of 6% to the 4–
24.3% range of several studies, and suggest that capsular rupture mayFig. 2. Intraoperative view of anterior surface of greater omentum with splenosis
implants.increase recurrence to 12.5% (Katkhouda et al., 1998). The lack of
Howell–Jolly bodies 13 years post-splenectomy suggests functional
splenotic nodules in our patient, thus a risk of ITP recurrence exists.
The majority of splenosis cases are found incidentally, and it has
rarely been reported as a primary pathologic process. As concisely
reviewed by Fremont et al.; “Pain secondary to infarction, intestinal
obstruction due to the adhesive bands of the splenic implants, gastro-
intestinal hemorrhage, hydronephrosis secondary to a growing mass
exerting pressure on the ureter, as well as an enlarging abdominal
mass with associated infection have all been reported (Fremont and
Todd, 2007).”
Imaging modalities such as ultrasound, CT, and MRI do not provide
conﬁrmatory diagnosis. Splenosis may resemble normal splenic tissue
upon these imaging techniques, and none can exclude carcinomatosis
(Lake et al., 2012; Ksiadzyna and Peña, 2011). Many radiologic and nu-
clear imaging techniques have been explored for non-invasive conﬁr-
mation of suspected splenosis, with 99 m Technetium heat-damaged
erythrocyte scintigraphy regarded as ideal due to preferential uptake
in splenic tissue with normal liver uptake (Ksiadzyna and Peña, 2011;
Malik et al., 2012).
PET scans assist oncologists in treatment planning and malignancy
response quantiﬁcation. Injection of labeled biologically active glu-
cose results in concentration of tracer in many tissues exhibiting
increased metabolic activity, a fundamental process in malignant
tumors (Aluddin, 2012). Quantiﬁcation of glucose metabolism is de-
pendent upon many variables, including basal glucose levels, stress,
volume of distribution, medications, in addition to standardized and
facility-speciﬁc protocols (Vriens et al., 2010).
A literature review found no reports of splenosis exhibiting PET
hypermetabolic activity. In fact, a recent case report of peritoneal
splenosis mimicking carcinomatosis used negative PET ﬁndings in sup-
port of primary laparoscopy instead of laparotomy in a patient with his-
tory of cervical cancer (Ake et al., 2012). While PET signal may be
inﬂuenced by habitus and glucoregulation, this morbidly obese patient
was not diabetic, fasted properly prior to the study, had a normal glu-
cose level (93 mg/dL), and underwent a standardized protocol with
fused PET–CT images and appropriate uptake phase of 60 min.
Direct visualization and tissue biopsy are the ideal means of char-
acterizing a suspected malignant intra-abdominal process. This pa-
tient had normal tumor marker levels and resolution of symptoms,
but ominous CT and PET ﬁndings. Given this clinical picture, we
proceeded with planned laparotomy for debulking surgery. Her sur-
gery and recovery were uncomplicated and the ﬁndings provided
her with great relief. In retrospect, scintigraphy may have added in-
formation to suggest a preoperative diagnosis of splenosis. In this
case, visual and tissue conﬁrmation could have been accomplished
by laparoscopy. In this patient's clinical scenario we feel that visual
and pathologic conﬁrmation is mandatory. The vascular nature of
splenic implants may increase the risk for hemorrhage with CT or
ultrasound-guided biopsy, and this method would not provide for vi-
sual survey of the abdominopelvic cavity.Conclusions
Splenosis is a rare phenomenon that may be mistaken for carcino-
matosis upon standard imaging techniques. PET is routinely used to bet-
ter characterize an abdominopelvic process suspicious for malignancy.
Inworkup of novel carcinomatosis in patientswith history of abdominal
traumaor splenectomy, splenosis should be part of the differential diag-
nosis, and consideration of nuclear imaging modalities including PET
scan, scintigraphy, and diagnostic laparoscopy should all be considered
prior to proceeding with laparotomy.Conﬂict of interest statement
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